Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
<15 |
15-19 |
20-24 |
25-29 |
30-34 |
35-39 |
40-44 |
45+ |
Age known |
Age not known |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Czech Republic |
1 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
5 |
1 |
6 |
Germany |
90 |
588 |
106 |
23 |
1 |
3 |
0 |
1 |
812 |
0 |
812 |
Greece |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
Latvia |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
Netherlands |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
53 |
53 |
Slovakia |
0 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
0 |
3 |
Finland |
0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
2 |
Notes: The number of treatment clients in each country is listed in [Table TDI-7]. Source: 2004 Reitox national reports - TDI outpatient treatment centres |